Literature DB >> 32504189

Update on the Acute Effects of Glucose, Insulin, and Incretins on Bone Turnover In Vivo.

Vanessa D Sherk1, Irene Schauer2,3, Viral N Shah4.   

Abstract

PURPOSE OF REVIEW: To provide an update on the acute effects of glucose, insulin, and incretins on markers of bone turnover in those with and without diabetes. RECENT
FINDINGS: Bone resorption is suppressed acutely in response to glucose and insulin challenges in both healthy subjects and patients with diabetes. The suppression is stronger with oral glucose compared with intravenous delivery. Stronger responses with oral glucose may be related to incretin effects on insulin secretion or from a direct effect on bone turnover. Glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-2 (GLP-2) infusion acutely suppresses bone resorption without much effect on bone formation. The bone turnover response to a metabolic challenge may be attenuated in type 2 diabetes, but this is an understudied area. A knowledge gap exists regarding bone turnover responses to a metabolic challenge in type 1 diabetes. The gut-pancreas-bone link is potentially an endocrine axis. This linkage is disrupted in diabetes, but the mechanism and progression of this disruption are not understood.

Entities:  

Keywords:  Bone turnover; Glycemic control; Incretin; Insulin; Type 1 diabetes; Type 2 diabetes

Year:  2020        PMID: 32504189      PMCID: PMC8118128          DOI: 10.1007/s11914-020-00598-z

Source DB:  PubMed          Journal:  Curr Osteoporos Rep        ISSN: 1544-1873            Impact factor:   5.096


  62 in total

1.  GLP-2 and GIP exert separate effects on bone turnover: A randomized, placebo-controlled, crossover study in healthy young men.

Authors:  Kirsa Skov-Jeppesen; Maria S Svane; Christoffer Martinussen; Maria B N Gabe; Lærke S Gasbjerg; Simon Veedfald; Kirstine N Bojsen-Møller; Sten Madsbad; Jens J Holst; Mette M Rosenkilde; Bolette Hartmann
Journal:  Bone       Date:  2019-05-15       Impact factor: 4.398

Review 2.  Incretin hormones: Their role in health and disease.

Authors:  Michael A Nauck; Juris J Meier
Journal:  Diabetes Obes Metab       Date:  2018-02       Impact factor: 6.577

3.  Glucose-Dependent Insulinotropic Polypeptide (GIP) Inhibits Bone Resorption Independently of Insulin and Glycemia.

Authors:  Mikkel B Christensen; Asger Lund; Salvatore Calanna; Niklas R Jørgensen; Jens J Holst; Tina Vilsbøll; Filip K Knop
Journal:  J Clin Endocrinol Metab       Date:  2018-01-01       Impact factor: 5.958

4.  Reduction of nocturnal rise in bone resorption by subcutaneous GLP-2.

Authors:  Dennis B Henriksen; Peter Alexandersen; Inger Byrjalsen; Bolette Hartmann; Henry G Bone; Claus Christiansen; Jens Juul Holst
Journal:  Bone       Date:  2004-01       Impact factor: 4.398

5.  Beneficial effects of a N-terminally modified GIP agonist on tissue-level bone material properties.

Authors:  Guillaume Mabilleau; Aleksandra Mieczkowska; Nigel Irwin; Yannick Simon; Maurice Audran; Peter R Flatt; Daniel Chappard
Journal:  Bone       Date:  2014-03-01       Impact factor: 4.398

6.  Differences in biochemical bone markers by diabetes type and the impact of glucose.

Authors:  Jakob Starup-Linde; Simon Lykkeboe; Søren Gregersen; Ellen-Margrethe Hauge; Bente Lomholt Langdahl; Aase Handberg; Peter Vestergaard
Journal:  Bone       Date:  2015-11-10       Impact factor: 4.398

7.  Bone Turnover Is Suppressed in Insulin Resistance, Independent of Adiposity.

Authors:  Katherine T Tonks; Christopher P White; Jacqueline R Center; Dorit Samocha-Bonet; Jerry R Greenfield
Journal:  J Clin Endocrinol Metab       Date:  2017-04-01       Impact factor: 5.958

8.  Contemporary risk of hip fracture in type 1 and type 2 diabetes: a national registry study from Scotland.

Authors:  Eleanor J Hothersall; Shona J Livingstone; Helen C Looker; S Faisal Ahmed; Steve Cleland; Graham P Leese; Robert S Lindsay; John McKnight; Donald Pearson; Sam Philip; Sarah H Wild; Helen M Colhoun
Journal:  J Bone Miner Res       Date:  2014       Impact factor: 6.741

Review 9.  Fracture risk in patients with type 2 diabetes mellitus and possible risk factors: a systematic review and meta-analysis.

Authors:  Ardeshir Moayeri; Mahmoud Mohamadpour; Seyedeh Fatemeh Mousavi; Ehsan Shirzadpour; Safoura Mohamadpour; Mansour Amraei
Journal:  Ther Clin Risk Manag       Date:  2017-04-11       Impact factor: 2.423

10.  Circulating Undercarboxylated Osteocalcin as Estimator of Cardiovascular and Type 2 Diabetes Risk in Metabolic Syndrome Patients.

Authors:  Blanca Riquelme-Gallego; Laura García-Molina; Naomi Cano-Ibáñez; Guillermo Sánchez-Delgado; Francisco Andújar-Vera; Cristina García-Fontana; Sheila González-Salvatierra; Enrique García-Recio; Virginia Martínez-Ruiz; Aurora Bueno-Cavanillas; Manuel Muñoz-Torres; Beatriz García-Fontana
Journal:  Sci Rep       Date:  2020-02-04       Impact factor: 4.379

View more
  2 in total

1.  Bone metabolism and incretin hormones following glucose ingestion in young adults with pancreatic insufficient cystic fibrosis.

Authors:  Wang Shin Lei; Marissa J Kilberg; Babette S Zemel; Ronald C Rubenstein; Clea Harris; Saba Sheikh; Andrea Kelly; Joseph M Kindler
Journal:  J Clin Transl Endocrinol       Date:  2022-09-03

Review 2.  Future studies using histomorphometry in type 1 diabetes mellitus.

Authors:  Laura A Graeff-Armas; Emily Silverman; Robert R Recker
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2021-08-01       Impact factor: 3.626

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.